Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies

Background— The aim of the present study was to estimate the impact of inherited thrombophilia (IT) on the risk of venous thromboembolism (VTE) onset and recurrence in children by a meta-analysis of published observational studies. Methods and Results— A systematic search of electronic databases (Medline, EMBASE, OVID, Web of Science, The Cochrane Library) for studies published from 1970 to 2007 was conducted using key words in combination as both MeSH terms and text words. Citations were independently screened by 2 authors, and those meeting the inclusion criteria defined a priori were retained. Data on year of publication, study design, country of origin, number of patients/controls, ethnicity, VTE type, and frequency of recurrence were abstracted. Heterogeneity across studies was evaluated, and summary odds ratios and 95% CIs were calculated with both fixed-effects and random-effects models. Thirty-five of 50 studies met inclusion criteria. No significant heterogeneity was discerned across studies. Although >70% of patients had at least 1 clinical risk factor for VTE, a statistically significant association with VTE onset was demonstrated for each IT trait evaluated (and for combined IT traits), with summary odds ratios ranging from 2.63 (95% CI, 1.61 to 4.29) for the factor II variant to 9.44 (95% CI, 3.34 to 26.66) for antithrombin deficiency. Furthermore, a significant association with recurrent VTE was found for all IT traits except the factor V variant and elevated lipoprotein(a). Conclusions— The present meta-analysis indicates that detection of IT is clinically meaningful in children with, or at risk for, VTE and underscores the importance of pediatric thrombophilia screening programs.

[1]  S. Burdach,et al.  Thrombophilia , 2021, Handbook of Pediatric Hematology and Oncology.

[2]  N. Goldenberg,et al.  Venous thromboembolism in children. , 2008, Pediatric clinics of North America.

[3]  E. Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[4]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].

[5]  J. Dietrich,et al.  Efficacy of family history in determining thrombophilia risk. , 2007, Journal of pediatric and adolescent gynecology.

[6]  F. Sofi,et al.  Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. , 2007, The American journal of medicine.

[7]  F. Kirkham,et al.  Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study , 2007, The Lancet Neurology.

[8]  E. Ozyurek,et al.  Antiphospholipid antibodies in Turkish children with thrombosis , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  Anthony K. C. Chan,et al.  Thromboembolic complications in pediatric hematologic malignancies. , 2007, Seminars in thrombosis and hemostasis.

[10]  S. Aysun,et al.  Significance of Factor V, Prothrombin, MTHFR, and PAI-1 Genotypes in Childhood Cerebral Thrombosis , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[11]  P. Prandoni,et al.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.

[12]  H. Platokouki,et al.  Mutations and Polymorphisms in Genes Affecting Haemostasis Components in Children with Thromboembolic Events , 2007, Pathophysiology of Haemostasis and Thrombosis.

[13]  S. Revel-Vilk,et al.  Antiphospholipid syndrome and recurrent thrombosis in children. , 2006, Arthritis and rheumatism.

[14]  A. Moeller,et al.  Congenital Prothrombotic Disorders in Children with Peripheral Venous and Arterial Thromboses , 2006, Acta Haematologica.

[15]  H. Savoia,et al.  Venous thromboembolic disease: A single‐centre case series study , 2006, Journal of paediatrics and child health.

[16]  Roger M Harbord,et al.  A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.

[17]  P. Simioni,et al.  Thrombosis and thrombophilia in children: a systematic review. , 2006, Seminars in thrombosis and hemostasis.

[18]  L. Iacoviello,et al.  Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. , 2006, Blood.

[19]  R. Aggarwal,et al.  Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India. , 2006, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[20]  R. Junker,et al.  Familial Elevated Factor VIII in Children With Symptomatic Venous Thrombosis and Post-Thrombotic Syndrome: Results of a Multicenter Study , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Moineddin,et al.  Portal vein thrombosis in the neonate: risk factors, course, and outcome. , 2006, The Journal of pediatrics.

[22]  S. Kaplan,et al.  Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children , 2006, Pediatrics.

[23]  C. Manno,et al.  Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. , 2006, The Journal of pediatrics.

[24]  G. Hankey,et al.  Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. , 2006, Archives of internal medicine.

[25]  M. Bonduel,et al.  Arterial Ischemic Stroke and Cerebral Venous Thrombosis in Children: A 12-Year Argentinean Registry , 2006, Acta Haematologica.

[26]  L. Brandão,et al.  Exercise-Induced Deep Vein Thrombosis of the Upper Extremity , 2006, Acta Haematologica.

[27]  L. Brandão,et al.  Exercise-Induced Deep Vein Thrombosis of the Upper Extremity , 2006, Acta Haematologica.

[28]  A. Wade,et al.  Perinatal renal venous thrombosis: presenting renal length predicts outcome , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[29]  J. Journeycake,et al.  Post-thrombotic syndrome is uncommon in childhood cancer survivors. , 2006, The Journal of pediatrics.

[30]  J. Miguel,et al.  Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[31]  B. Baytan,et al.  THE INFLUENCE OF RISK FACTORS IN PROMOTING THROMBOSIS DURING CHILDHOOD: The Role of Acquired Factors , 2006, Pediatric hematology and oncology.

[32]  F. Rosendaal,et al.  Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[33]  N. Rosenblum,et al.  Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. , 2005, The Journal of pediatrics.

[34]  R. Ljung,et al.  Risk factors for venous thrombosis in Swedish children and adolescents , 2005, Acta paediatrica.

[35]  V. Ganesan,et al.  Thrombophilia and first arterial ischaemic stroke: a systematic review , 2005, Archives of Disease in Childhood.

[36]  A. Wade,et al.  Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. , 2005, Brain : a journal of neurology.

[37]  Kevork Hopayian,et al.  Essential Evidence-based Medicine , 2005, ACP Journal Club.

[38]  A. Varan,et al.  Evaluation of thrombotic children with malignancy , 2005, Annals of Hematology.

[39]  A. Biswas,et al.  Protein C system defects in Indian children with thrombosis , 2005, Annals of Hematology.

[40]  F. Wesenberg,et al.  DIAGNOSTIC VALUE OF FAMILY HISTORIES OF THROMBOSIS TO IDENTIFY CHILDREN WITH THROMBOPHILIA , 2005, Pediatric hematology and oncology.

[41]  F. Gumruk,et al.  Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[42]  A. Toren,et al.  Paediatric cerebral sinus vein thrombosis , 2004, Thrombosis and Haemostasis.

[43]  M. Manco‐Johnson,et al.  Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. , 2004, The New England journal of medicine.

[44]  K. Kurnik,et al.  Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. , 2004, Blood.

[45]  Giancarlo Agnelli,et al.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[46]  E. Bandinelli,et al.  Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. , 2004, Journal of pediatric surgery.

[47]  P. Monagle,et al.  Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[48]  M. Kotb,et al.  Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study , 2004, Annals of Hematology.

[49]  M. Levy,et al.  Deep venous thrombosis in children and adolescents. , 2004, Journal of neurosurgery.

[50]  J. Mountz,et al.  Functional assessment of pulmonary vein stenosis using radionuclide ventilation/perfusion imaging. , 2004, Chest.

[51]  A. Daneman,et al.  Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound 1 , 2004, Journal of thrombosis and haemostasis : JTH.

[52]  C. Vergin,et al.  ANALYSIS OF PEDIATRIC THROMBOTIC PATIENTS IN TURKEY , 2004, Pediatric hematology and oncology.

[53]  M. Peters,et al.  Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome , 2003, Journal of thrombosis and haemostasis : JTH.

[54]  D. Hébert,et al.  Thromboembolism in paediatric lupus patients , 2003, Lupus.

[55]  A. von Eckardstein,et al.  Cerebral Venous Thrombosis in Children: A Multifactorial Origin , 2003, Circulation.

[56]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[57]  J. Journeycake,et al.  Thrombotic complications of central venous catheters in children , 2003, Current opinion in hematology.

[58]  E. Ma,et al.  Symptomatic venous thromboembolism in Hong Kong Chinese children. , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.

[59]  M. Bonduel,et al.  Factor V leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism , 2003, American journal of hematology.

[60]  S. Revel-Vilk,et al.  Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease 1 , 2003, Journal of thrombosis and haemostasis : JTH.

[61]  J. Gill,et al.  Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study , 2003, Journal of thrombosis and haemostasis : JTH.

[62]  N. Akar,et al.  Factor V Leiden and Prothrombin Gene 20210A Variant in Neonatal Thromboembolism and in Healthy Neonates and Adults: A Study in a Single Center , 2003, Pediatric hematology and oncology.

[63]  E. Chalmers,et al.  The investigation and management of neonatal haemostasis and thrombosis * , 2002, British journal of haematology.

[64]  P. Prandoni,et al.  The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. , 2002, Blood.

[65]  H. Büller,et al.  The risk of postthrombotic syndrome in children with congenital heart disease. , 2002, The Journal of pediatrics.

[66]  E. Neufeld,et al.  Risk factors for thromboembolism in teens: when should I test? , 2002, Current opinion in pediatrics.

[67]  M. Bonduel,et al.  Factor V Leiden and Prothrombin Gene G20210A Mutation in Children with Venous Thromboembolism , 2002, Thrombosis and Haemostasis.

[68]  S. Atalay,et al.  Factor V 1691 G‐A mutation in children with intracardiac thrombosis: a prospective study , 2002, Acta paediatrica.

[69]  H. Büller,et al.  Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. , 2001, The Journal of pediatrics.

[70]  C. Male,et al.  Homozygous Antithrombin Deficiency Type II (99 Leu to Phe Mutation) and Childhood Thromboembolism , 2001, Thrombosis and Haemostasis.

[71]  C. Camfield,et al.  Cerebral sinovenous thrombosis in children. , 2001, The New England journal of medicine.

[72]  A. Gurgey,et al.  Outcome of Noncatheter-Related Thrombosis in Children: Influence of Underlying or Coexisting Factors , 2001, Journal of pediatric hematology/oncology.

[73]  P. Joshua,et al.  Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. , 2001, Blood.

[74]  A. von Eckardstein,et al.  Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. , 2001, Blood.

[75]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study , 2000, British journal of haematology.

[76]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. , 2000 .

[77]  R. Junker,et al.  Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. , 2000, Thrombosis research.

[78]  S. Israels,et al.  Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia Registry , 2000, Pediatric Research.

[79]  W. Kreuz,et al.  Prothrombotic risk factors in childhood stroke and venous thrombosis , 1999, European Journal of Pediatrics.

[80]  R. Junker,et al.  Role of genetic prothrombotic risk factors in childhood caval vein thrombosis , 1999, European Journal of Pediatrics.

[81]  R. Knöfler,et al.  Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines , 1999, European Journal of Pediatrics.

[82]  M. Prins,et al.  The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. , 1999, Blood.

[83]  R. Junker,et al.  Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood , 1999, European Journal of Pediatrics.

[84]  R. Junker,et al.  Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[85]  A. von Eckardstein,et al.  Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. , 1999, Circulation.

[86]  M. D. Williams,et al.  Congenital thrombophilia and thrombosis: a study in a single centre , 1999, Archives of disease in childhood.

[87]  M. Bonduel,et al.  Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. , 1999, Archives of neurology.

[88]  P. Riikonen,et al.  Clinically symptomatic central venous catheter‐related deep venous thrombosis in newborns , 1999, Acta paediatrica.

[89]  R. Junker,et al.  Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. , 1999, Blood.

[90]  D. Steinberg,et al.  Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[91]  M. Prins,et al.  Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia , 1999, Thrombosis and Haemostasis.

[92]  A. Ganser,et al.  Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[93]  K. Raivio,et al.  Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants , 1999, European Journal of Pediatrics.

[94]  F. Cameron,et al.  Pituitary dysfunction, morbidity and mortality with congenital midline malformation of the cerebrum , 1999, European Journal of Pediatrics.

[95]  G. deVeber,et al.  Prothrombotic disorders in infants and children with cerebral thromboembolism. , 1998, Archives of neurology.

[96]  R. Bluebond-Langner,et al.  Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease. , 1998 .

[97]  V. Arruda,et al.  Inherited risk factors for thrombophilia in children with nephrotic syndrome , 1998, European Journal of Pediatrics.

[98]  A. Gürgey,et al.  Prothrombin gene 20210 G‐A mutation in Turkish patients with thrombosis , 1998, American journal of hematology.

[99]  U. Nowak‐Göttl,et al.  Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia , 1998, European Journal of Pediatrics.

[100]  P. Reitsma,et al.  Geographic Distribution of the 20210 G to A Prothrombin Variant , 1998, Thrombosis and Haemostasis.

[101]  S. Hunger,et al.  Activated protein C resistance and the factor V Leiden mutation in children with thrombosis , 1998, American journal of hematology.

[102]  J. Sampol,et al.  Thrombosis in congenital deficiencies of AT III, protein C or protein S: a study of 44 children. , 1997, Hematology and cell therapy.

[103]  M. Prins,et al.  Recurrence of venous thromboembolism in patients with familial thrombophilia. , 1997, Archives of internal medicine.

[104]  U. Nowak‐Göttl,et al.  Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. , 1997, The Journal of pediatrics.

[105]  A. Gürgey,et al.  The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey. , 1997, The Turkish journal of pediatrics.

[106]  R. von Kries,et al.  Neonatal symptomatic thromboembolism in Germany: two year survey , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[107]  G. Gaedicke,et al.  Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency , 1997, European Journal of Pediatrics.

[108]  S. Hunger,et al.  The factor V Leiden mutation in children with cancer and thrombosis , 1997, British journal of haematology.

[109]  V. Arruda,et al.  Factor V Leiden Is Not Common in Children with Portal Vein Thrombosis , 1997, Thrombosis and Haemostasis.

[110]  B. Giusti,et al.  Prevalence of Factor V Leiden Mutation in Non-European Populations , 1997, Thrombosis and Haemostasis.

[111]  U. Nowak‐Göttl,et al.  Prevalence of factor V Leiden in children with thrombo-embolism , 1996, European Journal of Pediatrics.

[112]  D. Rees.  The Population Genetics of Factor V Leiden (Arg506Gln) , 1996, British journal of haematology.

[113]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[114]  L. Mesci,et al.  Factor V Q 506 mutation in children with thrombosis , 1996, American journal of hematology.

[115]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[116]  H. Jürgens,et al.  Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism , 1996, British journal of haematology.

[117]  J. Griffin,et al.  Thrombosis in otherwise well children with the factor V Leiden mutation. , 1996, The Journal of pediatrics.

[118]  B. Schmidt,et al.  Neonatal thrombosis: report of a prospective Canadian and international registry. , 1995, Pediatrics.

[119]  P. Monagle,et al.  Antithrombotic therapy in children. , 1995, Current opinion in pediatrics.

[120]  M. Andrew.  Developmental Hemostasis: Relevance to Thromboembolic Complications in Pediatric Patients , 1995, Thrombosis and Haemostasis.

[121]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[122]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[123]  A. Suppiej,et al.  Cerebral sinovenous thrombosis in children: thrombophilia and clinical outcome. , 2008, Thrombosis research.

[124]  L. Williams,et al.  Family history is a poor screen for prothrombotic genes in children with stroke. , 2006, The Journal of pediatrics.

[125]  G. Leone,et al.  The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. , 2006, Haematologica.

[126]  Copyright , 2005, DFT.

[127]  S. Kuhle,et al.  A cross-sectional study evaluating post-thrombotic syndrome in children. , 2003, Thrombosis research.

[128]  Giuseppe Leone,et al.  Screening for inherited thrombophilia: indications and therapeutic implications. , 2002, Haematologica.

[129]  M. Bonduel,et al.  Prothrombotic abnormalities in children with venous thromboembolism. , 2000, Journal of pediatric hematology/oncology.

[130]  J. Miletich.  Thrombophilia as a multigenic disorder. , 1998, Seminars in thrombosis and hemostasis.

[131]  M. Manco-Johnson,et al.  Childhood thrombosis. , 1995, Pediatrics.

[132]  Medical Statistics , 1958, Nature.